These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25585955)

  • 21. PLGA-Listeriolysin O microspheres: Opening the gate for cytosolic delivery of cancer antigens.
    Gilert A; Baruch L; Bronshtein T; Machluf M
    Biomed Microdevices; 2016 Apr; 18(2):23. PubMed ID: 26888439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
    He JT; Su HB; Li GP; Tao XM; Mo W; Song HY
    Int J Pharm; 2006 Feb; 309(1-2):101-8. PubMed ID: 16413979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation of bleomycin A2-PLGA microspheres and related in vitro and in vivo studies.
    Zhang H; Gao Y; Lv W; Jiao C; Duan M; Liu H; Han B
    J Pharm Sci; 2011 Jul; 100(7):2790-800. PubMed ID: 21344412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation of uniform-sized exenatide-loaded PLGA microspheres as long-effective release system with high encapsulation efficiency and bio-stability.
    Qi F; Wu J; Fan Q; He F; Tian G; Yang T; Ma G; Su Z
    Colloids Surf B Biointerfaces; 2013 Dec; 112():492-8. PubMed ID: 24075786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Setting accelerated dissolution test for PLGA microspheres containing peptide, investigation of critical parameters affecting drug release rate and mechanism.
    Tomic I; Vidis-Millward A; Mueller-Zsigmondy M; Cardot JM
    Int J Pharm; 2016 May; 505(1-2):42-51. PubMed ID: 27025293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein bioactivity and polymer orientation is affected by stabilizer incorporation for double-walled microspheres.
    Kokai LE; Tan H; Jhunjhunwala S; Little SR; Frank JW; Marra KG
    J Control Release; 2010 Jan; 141(2):168-76. PubMed ID: 19751780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin loaded PLGA microspheres: effect of zinc salts on encapsulation, release, and stability.
    Manoharan C; Singh J
    J Pharm Sci; 2009 Feb; 98(2):529-42. PubMed ID: 18548615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acylation of arginine in goserelin-loaded PLGA microspheres.
    Shirangi M; Hennink WE; Somsen GW; van Nostrum CF
    Eur J Pharm Biopharm; 2016 Feb; 99():18-23. PubMed ID: 26607434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pluronic F127 gel effectively controls the burst release of drug from PLGA microspheres.
    Wang Y; Gao JQ; Chen HL; Zheng CH; Liang WQ
    Pharmazie; 2006 Apr; 61(4):367-8. PubMed ID: 16649559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Highly porous large poly(lactic-co-glycolic acid) microspheres adsorbed with palmityl-acylated exendin-4 as a long-acting inhalation system for treating diabetes.
    Kim H; Park H; Lee J; Kim TH; Lee ES; Oh KT; Lee KC; Youn YS
    Biomaterials; 2011 Feb; 32(6):1685-93. PubMed ID: 21126761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications.
    Ma G
    J Control Release; 2014 Nov; 193():324-40. PubMed ID: 25218676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation of peptide microspheres using tumor antigen-derived peptides.
    Bhatnagar S; Naqvi RA; Ali R; Rao DN
    Methods Mol Biol; 2014; 1139():443-52. PubMed ID: 24619698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
    Jackson JK; Hung T; Letchford K; Burt HM
    Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B.
    Jaganathan KS; Singh P; Prabakaran D; Mishra V; Vyas SP
    J Pharm Pharmacol; 2004 Oct; 56(10):1243-50. PubMed ID: 15482638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of acidic pH on PLGA microsphere degradation and release.
    Zolnik BS; Burgess DJ
    J Control Release; 2007 Oct; 122(3):338-44. PubMed ID: 17644208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of ciclosporin A loaded poly (D,L lactide-co-glycolide) microspheres using modulated temperature differential scanning calorimetry.
    Passerini N; Craig DQ
    J Pharm Pharmacol; 2002 Jul; 54(7):913-9. PubMed ID: 12162709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine-loaded poly(D,L-lactic-co-glycolic acid) microspheres: new strategy for encapsulating small hydrophilic drugs with high efficiency.
    Shin M; Kim HK; Lee H
    Biotechnol Prog; 2014; 30(1):215-23. PubMed ID: 24281843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlling degradation of acid-hydrolyzable pluronic hydrogels by physical entrapment of poly(lactic acid-co-glycolic acid) microspheres.
    Lee JB; Chun KW; Yoon JJ; Park TG
    Macromol Biosci; 2004 Oct; 4(10):957-62. PubMed ID: 15487026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
    Desai KG; Mallery SR; Schwendeman SP
    Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro degradation of nanoparticles prepared from polymers based on DL-lactide, glycolide and poly(ethylene oxide).
    Zweers ML; Engbers GH; Grijpma DW; Feijen J
    J Control Release; 2004 Dec; 100(3):347-56. PubMed ID: 15567501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.